WSU-30930-06478 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-03
Dose 1 — Pfizer-BioNTech
2021-04-24
Dose 2 — Pfizer-BioNTech
2021-11-05
Registered in v-safe
2021-11-05
Dose 3 — Pfizer-BioNTech
2021-11-05
Health check-in — day 0, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2021-11-06
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-11-07
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-11-08
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-11-11
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-12
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-11-19
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-11-26
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-12-03
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-12-10
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-12-17
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-02-04
Survey response — 3 months, dose 3
MedDRA: Dysmenorrhoea, Heavy menstrual bleeding — Feeling: Good

Free text: Much heavier, longer menstrual cycle. Cramps were also very bad.

MedDRA releases: 2024-11 · check-in free text available
2022-05-08
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-09-23
Dose 4 — Pfizer-BioNTech
2022-09-24
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-09-25
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Headache, Muscle or body aches

Adult check-in
2022-09-26
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-09-27
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-09-28
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Fatigue or tiredness

Adult check-in
2022-09-29
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-09-30
Health check-in — day 7, dose 4
Feeling: Good · None

Adult check-in
2022-10-07
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-10-14
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-10-21
Survey response — day 28, dose 4
MedDRA: Headache — Feeling: Fair · Be unable to work or attend school

Free text: Headache

MedDRA releases: 2024-11 · check-in free text available
2022-10-28
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-11-04
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2022-12-23
Health check-in — 3 months, dose 4
Feeling: Fair

Adult check-in
2023-03-24
Survey response — 6 months, dose 4
MedDRA: Gestational hypertension — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

MedDRA releases: 2024-11
2023-03-24
Report sent to call center — 6 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2023-03-27
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-03	Pfizer-BioNTech	No
2	2021-04-24	Pfizer-BioNTech	No
3	2021-11-05	Pfizer-BioNTech	No
4	2022-09-23	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2023-03-24	Unsuccessful

Free text

Release 11 — 3 months, dose 3

2022-02-04

Symptoms: Much heavier, longer menstrual cycle. Cramps were also very bad.

Release 12 — day 28, dose 4

2022-10-21

Symptoms: Headache

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dysmenorrhoea	·	·	✓
SD	Gestational hypertension	·	·	✓
SD	Headache	·	·	✓
SD	Heavy menstrual bleeding	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release